Mineral metabolites and CKD progression in African Americans

Julia J. Scialla, Brad C. Astor, Tamara Isakova, Huiliang Xie, Lawrence J. Appel, Myles Wolf

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

CKD progresses more rapidly to ESRD among African Americans compared with Caucasians. Disordered mineral metabolism is more severe among African Americans with CKD, which might partially explain the accelerated progression of their kidney disease. Here, using data from the African American Study of Kidney Disease and Hypertension, we evaluated longitudinal changes in serum levels of fibroblast growth factor-23 (FGF23), parathyroid hormone (PTH), phosphate, and 25-hydroxyvitamin D in a subset of 420 participants followed for a median of 4 years. We also examined the association of baseline levels of mineral metabolites with risk for ESRD or death in 809 participants. FGF23, PTH, and phosphate levels rose over time; participants with faster rates of decline in measured GFR had the greatest increases in these parameters (P<0.01 for each).Higher baseline levels of FGF23, PTH, and phosphate each associated with increased risk for ESRD or death independent of GFR. FGF23 exhibited a dose-response relationship with outcomes (HR=1.30 per doubling, 95% CI=1.15-1.47; HR=2.24 for highest compared with lowest quartile, 95% CI=1.39-3.60), whereas PTH and phosphate showed nonlinear relationships. Vitamin D insufficiency (<30 ng/ml) was present in 95% of participants, but lower levels did not independently associate with outcomes. Using death-censored ESRD as the outcome produced qualitatively similar results. In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis.

Original languageEnglish
Pages (from-to)125-135
Number of pages11
JournalJournal of the American Society of Nephrology
Volume24
Issue number1
DOIs
StatePublished - Dec 28 2013

Fingerprint

African Americans
Chronic Kidney Failure
Minerals
Parathyroid Hormone
Phosphates
Kidney Diseases
Nephrosclerosis
Vitamin D
Hypertension
fibroblast growth factor 23
Serum

ASJC Scopus subject areas

  • Nephrology

Cite this

Scialla, J. J., Astor, B. C., Isakova, T., Xie, H., Appel, L. J., & Wolf, M. (2013). Mineral metabolites and CKD progression in African Americans. Journal of the American Society of Nephrology, 24(1), 125-135. https://doi.org/10.1681/ASN.2012070713

Mineral metabolites and CKD progression in African Americans. / Scialla, Julia J.; Astor, Brad C.; Isakova, Tamara; Xie, Huiliang; Appel, Lawrence J.; Wolf, Myles.

In: Journal of the American Society of Nephrology, Vol. 24, No. 1, 28.12.2013, p. 125-135.

Research output: Contribution to journalArticle

Scialla, JJ, Astor, BC, Isakova, T, Xie, H, Appel, LJ & Wolf, M 2013, 'Mineral metabolites and CKD progression in African Americans', Journal of the American Society of Nephrology, vol. 24, no. 1, pp. 125-135. https://doi.org/10.1681/ASN.2012070713
Scialla, Julia J. ; Astor, Brad C. ; Isakova, Tamara ; Xie, Huiliang ; Appel, Lawrence J. ; Wolf, Myles. / Mineral metabolites and CKD progression in African Americans. In: Journal of the American Society of Nephrology. 2013 ; Vol. 24, No. 1. pp. 125-135.
@article{9deb9ebd4b9445b88482854ef1c686a4,
title = "Mineral metabolites and CKD progression in African Americans",
abstract = "CKD progresses more rapidly to ESRD among African Americans compared with Caucasians. Disordered mineral metabolism is more severe among African Americans with CKD, which might partially explain the accelerated progression of their kidney disease. Here, using data from the African American Study of Kidney Disease and Hypertension, we evaluated longitudinal changes in serum levels of fibroblast growth factor-23 (FGF23), parathyroid hormone (PTH), phosphate, and 25-hydroxyvitamin D in a subset of 420 participants followed for a median of 4 years. We also examined the association of baseline levels of mineral metabolites with risk for ESRD or death in 809 participants. FGF23, PTH, and phosphate levels rose over time; participants with faster rates of decline in measured GFR had the greatest increases in these parameters (P<0.01 for each).Higher baseline levels of FGF23, PTH, and phosphate each associated with increased risk for ESRD or death independent of GFR. FGF23 exhibited a dose-response relationship with outcomes (HR=1.30 per doubling, 95{\%} CI=1.15-1.47; HR=2.24 for highest compared with lowest quartile, 95{\%} CI=1.39-3.60), whereas PTH and phosphate showed nonlinear relationships. Vitamin D insufficiency (<30 ng/ml) was present in 95{\%} of participants, but lower levels did not independently associate with outcomes. Using death-censored ESRD as the outcome produced qualitatively similar results. In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis.",
author = "Scialla, {Julia J.} and Astor, {Brad C.} and Tamara Isakova and Huiliang Xie and Appel, {Lawrence J.} and Myles Wolf",
year = "2013",
month = "12",
day = "28",
doi = "10.1681/ASN.2012070713",
language = "English",
volume = "24",
pages = "125--135",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Mineral metabolites and CKD progression in African Americans

AU - Scialla, Julia J.

AU - Astor, Brad C.

AU - Isakova, Tamara

AU - Xie, Huiliang

AU - Appel, Lawrence J.

AU - Wolf, Myles

PY - 2013/12/28

Y1 - 2013/12/28

N2 - CKD progresses more rapidly to ESRD among African Americans compared with Caucasians. Disordered mineral metabolism is more severe among African Americans with CKD, which might partially explain the accelerated progression of their kidney disease. Here, using data from the African American Study of Kidney Disease and Hypertension, we evaluated longitudinal changes in serum levels of fibroblast growth factor-23 (FGF23), parathyroid hormone (PTH), phosphate, and 25-hydroxyvitamin D in a subset of 420 participants followed for a median of 4 years. We also examined the association of baseline levels of mineral metabolites with risk for ESRD or death in 809 participants. FGF23, PTH, and phosphate levels rose over time; participants with faster rates of decline in measured GFR had the greatest increases in these parameters (P<0.01 for each).Higher baseline levels of FGF23, PTH, and phosphate each associated with increased risk for ESRD or death independent of GFR. FGF23 exhibited a dose-response relationship with outcomes (HR=1.30 per doubling, 95% CI=1.15-1.47; HR=2.24 for highest compared with lowest quartile, 95% CI=1.39-3.60), whereas PTH and phosphate showed nonlinear relationships. Vitamin D insufficiency (<30 ng/ml) was present in 95% of participants, but lower levels did not independently associate with outcomes. Using death-censored ESRD as the outcome produced qualitatively similar results. In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis.

AB - CKD progresses more rapidly to ESRD among African Americans compared with Caucasians. Disordered mineral metabolism is more severe among African Americans with CKD, which might partially explain the accelerated progression of their kidney disease. Here, using data from the African American Study of Kidney Disease and Hypertension, we evaluated longitudinal changes in serum levels of fibroblast growth factor-23 (FGF23), parathyroid hormone (PTH), phosphate, and 25-hydroxyvitamin D in a subset of 420 participants followed for a median of 4 years. We also examined the association of baseline levels of mineral metabolites with risk for ESRD or death in 809 participants. FGF23, PTH, and phosphate levels rose over time; participants with faster rates of decline in measured GFR had the greatest increases in these parameters (P<0.01 for each).Higher baseline levels of FGF23, PTH, and phosphate each associated with increased risk for ESRD or death independent of GFR. FGF23 exhibited a dose-response relationship with outcomes (HR=1.30 per doubling, 95% CI=1.15-1.47; HR=2.24 for highest compared with lowest quartile, 95% CI=1.39-3.60), whereas PTH and phosphate showed nonlinear relationships. Vitamin D insufficiency (<30 ng/ml) was present in 95% of participants, but lower levels did not independently associate with outcomes. Using death-censored ESRD as the outcome produced qualitatively similar results. In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=84871915964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871915964&partnerID=8YFLogxK

U2 - 10.1681/ASN.2012070713

DO - 10.1681/ASN.2012070713

M3 - Article

C2 - 23243213

AN - SCOPUS:84871915964

VL - 24

SP - 125

EP - 135

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 1

ER -